As Cvs Health Corp (CVS) Stock Value Declined, Holder Matrix Asset Advisors INC Trimmed Its Stake

April 23, 2018 - By reb123z

CVS Health Corporation (NYSE:CVS) LogoInvestors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It worsened, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Wells Fargo And Mn stated it has 9.09M shares or 0.19% of all its holdings. Senzar Asset Mngmt Ltd holds 315,500 shares or 5.84% of its portfolio. 25,779 are held by Lowe Brockenbrough Co Incorporated. Mercer Capital Advisers accumulated 1,500 shares or 0.08% of the stock. Karpas Strategies Limited Liability holds 0.5% in CVS Health Corporation (NYSE:CVS) or 16,148 shares. Macquarie Grp Limited has 9.22M shares for 1.18% of their portfolio. Chatham Cap holds 0.1% or 4,905 shares. Riverpoint Mngmt Ltd Liability Co invested in 0.02% or 5,694 shares. Qci Asset Management Inc New York has 499 shares for 0% of their portfolio. Bowling Portfolio Mngmt Llc invested in 96,991 shares or 0.93% of the stock. Buckhead Cap Mngmt Limited accumulated 86,309 shares. Arrow owns 0.41% invested in CVS Health Corporation (NYSE:CVS) for 24,311 shares. Parnassus Investments Ca invested 2.05% in CVS Health Corporation (NYSE:CVS). Eads & Heald Inv Counsel has 15,824 shares for 0.68% of their portfolio. Natl Bank Of Nova Scotia Trust owns 9,607 shares for 0.08% of their portfolio.

Since February 16, 2018, it had 0 buys, and 1 insider sale for $1.42 million activity.

Matrix Asset Advisors Inc decreased its stake in Cvs Health Corp (CVS) by 41.47% based on its latest 2017Q4 regulatory filing with the SEC. Matrix Asset Advisors Inc sold 109,689 shares as the company’s stock declined 17.45% with the market. The institutional investor held 154,821 shares of the medical and nursing services company at the end of 2017Q4, valued at $11.23 million, down from 264,510 at the end of the previous reported quarter. Matrix Asset Advisors Inc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $66.20B market cap company. The stock decreased 0.37% or $0.24 during the last trading session, reaching $65.12. About 6.17M shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since April 23, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Matrix Asset Advisors Inc, which manages about $977.80 million and $630.20M US Long portfolio, upped its stake in Mondelez Intl Inc (NASDAQ:MDLZ) by 91,367 shares to 170,609 shares, valued at $7.30M in 2017Q4, according to the filing.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on May, 2 before the open. They expect $1.40 earnings per share, up 19.66 % or $0.23 from last year’s $1.17 per share. CVS’s profit will be $1.42 billion for 11.63 P/E if the $1.40 EPS becomes a reality. After $1.92 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -27.08 % negative EPS growth.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 14 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 4 Hold. Therefore 71% are positive. CVS Health has $95.0 highest and $73 lowest target. $84.18’s average target is 29.27% above currents $65.12 stock price. CVS Health had 32 analyst reports since October 27, 2017 according to SRatingsIntel. Leerink Swann maintained the shares of CVS in report on Friday, February 9 with “Outperform” rating. Tigress Financial maintained CVS Health Corporation (NYSE:CVS) on Tuesday, December 26 with “Buy” rating. Citigroup maintained the shares of CVS in report on Tuesday, February 13 with “Neutral” rating. On Tuesday, April 10 the stock rating was maintained by Leerink Swann with “Buy”. SunTrust maintained CVS Health Corporation (NYSE:CVS) rating on Thursday, January 4. SunTrust has “Buy” rating and $90.0 target. Robert W. Baird maintained the shares of CVS in report on Wednesday, January 17 with “Hold” rating. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Robert W. Baird on Thursday, January 4. The stock has “Buy” rating by Needham on Tuesday, January 30. Bank of America maintained it with “Buy” rating and $88 target in Wednesday, April 11 report. Needham maintained CVS Health Corporation (NYSE:CVS) rating on Monday, December 4. Needham has “Buy” rating and $85.0 target.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.